Role for nuclear factor-kappaB in augmented lung injury because of interaction between hyperoxia and high stretch ventilation.
High-tidal-volume mechanical ventilation and hyperoxia used in patients with acute lung injury (ALI) can induce alveolar coagulopathy and fibrin depositions within the airways. Hyperoxia has been shown to increase ventilator-induced lung injury (VILI), but the mechanisms that regulate interaction between high-tidal-volume mechanical ventilation and hyperoxia are unclear. We hypothesized that mechanical stretch with hyperoxia synergistically augmented neutrophil infiltration and production of plasminogen activator inhibitor-1 (PAI-1) via the nuclear factor-kappaB (NF-kappaB) pathway. C57BL/6 mice (n=5 per group) were exposed to high-tidal-volume (30 mL/kg) or low-tidal-volume (6 mL/kg) mechanical ventilation with room air or hyperoxia for 1 to 5h after 2-microg/g NF-kappaB inhibitor (SN-50) administration. Nonventilated mice with room air or hyperoxia served as control groups. Evans blue dye, myeloperoxidase, electrophoretic mobility shifting of nuclear protein, and inflammatory cytokine were measured. The expression of tumor necrosis factor-alpha (TNF-alpha) and PAI-1 were studied by immunohistochemistry. The addition of hyperoxia to high-tidal-volume ventilation-augmented lung injury, as demonstrated by increased microvascular leak, neutrophil migration into the lung, TNF-alpha and active PAI-1 production, DNA binding activity of NF-kappaB, and NF-kappaB activation. No statistically significant increase of neutrophil infiltration and inflammatory cytokine production was found in the mice ventilated at 6 mL/kg using hyperoxia. Hyperoxia-induced augmentation of VILI was attenuated in mice with pharmacologic inhibition of NF-kappaB activity by SN-50. We conclude that hyperoxia increased high-tidal-volume-induced cytokine production and neutrophil influx through activation of the NF-kappaB pathway.
Chest Department, Taipei Veterans General Hospital, and National Yang-Ming University, School of Medicine, Taipei, Taiwan.
Yung-Yang
YY
Liu
Shuen-Kuei
SK
Liao
Chung-Chi
CC
Huang
Ying-Huang
YH
Tsai
Deborah A
DA
Quinn
Li-Fu
LF
Li
D055371:Acute Lung Injury / Q000378:metabolism* / Q000473:pathology; D000818:Animals; D004247:DNA / Q000378:metabolism; D004195:Disease Models, Animal; D004211:Disseminated Intravascular Coagulation / Q000209:etiology* / Q000378:metabolism; D018496:Hyperoxia / Q000150:complications* / Q000378:metabolism; D008168:Lung / Q000378:metabolism / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000378:metabolism*; D020556:Neutrophil Infiltration; D009504:Neutrophils / Q000378:metabolism / Q000473:pathology; D010455:Peptides / Q000633:toxicity; D011485:Protein Binding; D012121:Respiration, Artificial / Q000009:adverse effects* / Q000379:methods; D058258:Serpin E2; D015843:Serpins / Q000378:metabolism; D013990:Tidal Volume
D016328:NF-kappa B; D010455:Peptides; C118258:SN50 peptide; D058258:Serpin E2; C511869:Serpine2 protein, mouse; D015843:Serpins; D004247:DNA